Tung PH - Search Results

1

Efficacy of portable sleep monitoring device in diagnosing central sleep apnea in patients with congestive heart failure.

Tung PH, Hsieh MJ, Chuang LP, Lin SW, Hung KC, Lu CH, Lee WC, Hu HC, Wen MS, Chen NH. Tung PH, et al. Front Neurol. 2022 Dec 21;13:1043413. doi: 10.3389/fneur.2022.1043413. eCollection 2022. Front Neurol. 2022. PMID: 36619927 Free PMC article.

2

Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.

Lin CH, Yeh JK, Lin TY, Lo YL, Chang BJ, Ju JS, Chiu TH, Tung PH, Huang YJ, Lin SM. Lin CH, et al. Among authors: tung ph. BMC Pulm Med. 2023 Feb 17;23(1):67. doi: 10.1186/s12890-023-02357-z. BMC Pulm Med. 2023. PMID: 36805703 Free PMC article.

3

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.

Chiu LC, Hsu PC, Wang CC, Ko HW, Kuo SC, Ju JS, Tung PH, Huang AC, Yang CT. Chiu LC, et al. Among authors: tung ph. Thorac Cancer. 2024 Mar;15(7):529-537. doi: 10.1111/1759-7714.15212. Epub 2024 Jan 26. Thorac Cancer. 2024. PMID: 38279515 Free PMC article.

4

Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.

Lee SH, Lin YC, Chiu LC, Ju JS, Tung PH, Huang AC, Li SH, Fang YF, Chen CH, Kuo SC, Wang CC, Yang CT, Hsu PC. Lee SH, et al. Among authors: tung ph. Ther Adv Med Oncol. 2022 Jul 23;14:17588359221113278. doi: 10.1177/17588359221113278. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35898964 Free PMC article.

5

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.

Kuo CS, Chiu TH, Tung PH, Huang CH, Ju JS, Huang AC, Wang CC, Ko HW, Hsu PC, Fang YF, Guo YK, Yang CT. Kuo CS, et al. Among authors: tung ph. Cancers (Basel). 2022 Jan 9;14(2):316. doi: 10.3390/cancers14020316. Cancers (Basel). 2022. PMID: 35053480 Free PMC article.

6

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.

Ju JS, Huang AC, Tung PH, Huang CH, Chiu TH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Ju JS, et al. Among authors: tung ph. Sci Rep. 2023 Nov 21;13(1):20323. doi: 10.1038/s41598-023-45815-8. Sci Rep. 2023. PMID: 37989860 Free PMC article.

7

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.

Kuo CS, Tung PH, Huang AC, Wang CC, Chang JW, Liu CY, Chung FT, Fang YF, Guo YK, Yang CT. Kuo CS, et al. Among authors: tung ph. BMC Cancer. 2021 Mar 24;21(1):309. doi: 10.1186/s12885-021-08005-1. BMC Cancer. 2021. PMID: 33761908 Free PMC article.

8

A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.

Wang CC, Chiu LC, Tung PH, Kuo SC, Chu CH, Huang AC, Wang CL, Chen CH, Yang CT, Hsu PC. Wang CC, et al. Among authors: tung ph. Oncol Ther. 2021 Dec;9(2):489-503. doi: 10.1007/s40487-021-00152-6. Epub 2021 May 15. Oncol Ther. 2021. PMID: 33990928 Free PMC article.

9

Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.

Huang CH, Ju JS, Chiu TH, Huang AC, Tung PH, Wang CC, Liu CY, Chung FT, Fang YF, Guo YK, Kuo CS, Yang CT. Huang CH, et al. Among authors: tung ph. Int J Cancer. 2022 Feb 15;150(4):626-635. doi: 10.1002/ijc.33821. Epub 2021 Oct 26. Int J Cancer. 2022. PMID: 34558665 Free article.

10

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.

Tung PH, Chiu TH, Huang AC, Ju JS, Huang CH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Tung PH, et al. Ther Adv Med Oncol. 2024 Jan 19;16:17588359231222604. doi: 10.1177/17588359231222604. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38249338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page